Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin

NCT00915811 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped FB ATG is now a standard for sib allo MDS patients

Conditions

Myelodysplastic Syndromes
Leukemia, Myeloid, Acute

Interventions

DRUG: Fludarabine
DRUG: Busulphan
DRUG: Thymoglobuline (Anti-thymocyte globulin [rabbit]) - Genzyme
PROCEDURE: Haematopoietic stem cell infusion

Sponsor

King's College Hospital NHS Trust